Completed NA INTERVENTIONAL NCT00000634
A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
Sponsor: Boehringer Ingelheim
Conditions
HIV Infections
Interventions
Nevirapine
Updated 5 times since 2017 Last updated: Feb 25, 2011 Primary completion: Jun 30, 1995
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on HIV Infections, this trial is completed. The trial is conducted by Boehringer Ingelheim and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Boehringer Ingelheim
- National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .